Lokelma (sodium zirconium cyclosilicate) typically lowers serum potassium by about 1.1 mmol/L (the same as 1.1 mEq/L) within the first 48 hours of treatment at the standard starting dose. In the HARMONIZE trial, potassium levels dropped from an average of 5.6 mEq/L at baseline to 4.5 mEq/L at 48 hours, with 98% of patients reaching normal potassium levels in that window. How much your potassium drops depends on your starting level, your dose, and how long you take it.
How Quickly Potassium Drops
Lokelma works faster than many people expect. Potassium levels start declining within one hour of the first dose, and the median time to reach a normal range (3.5 to 5.0 mmol/L) is just 2.2 hours. That said, the full effect builds over two days. Here’s the typical trajectory with a 10 g dose taken three times daily:
- 1 hour: about 0.2 mmol/L reduction
- 2 hours: about 0.4 mmol/L reduction
- 4 hours: about 0.5 mmol/L reduction
- 24 hours: about 0.7 mmol/L reduction
- 48 hours: about 1.1 mmol/L reduction
By 24 hours, 84% of patients in clinical trials had reached normal potassium levels. By 48 hours, that number climbed to 98%.
Your Starting Level Matters
The higher your potassium is when you start Lokelma, the larger the drop you can expect. In the HARMONIZE trial, patients starting at 6.0 mmol/L or above saw an average reduction of 1.5 mmol/L at 48 hours. Those starting between 5.5 and 5.9 mmol/L dropped by about 1.2 mmol/L. Patients with milder elevations (below 5.5 mmol/L) saw a smaller but still meaningful decrease of around 0.8 mmol/L.
This pattern is consistent across studies and makes intuitive sense. The drug works by trapping potassium in your gut and flushing it out through stool. When there’s more excess potassium circulating, there’s more for the drug to pull out.
How Different Doses Compare
During the initial correction phase (the first 48 hours), the standard dose is 10 g three times daily. After potassium normalizes, you typically switch to a once-daily maintenance dose of 5 g, 10 g, or 15 g, adjusted based on your lab results.
In one phase III trial that tested multiple doses over 48 hours (each given three times daily), the potassium reductions were clearly dose-dependent:
- 1.25 g: 0.30 mmol/L drop
- 2.5 g: 0.46 mmol/L drop
- 5 g: 0.54 mmol/L drop
- 10 g: 0.73 mmol/L drop
For longer-term maintenance over 28 days, the once-daily doses showed a similar pattern. Patients on 5 g daily had potassium reductions averaging 0.8 mmol/L, those on 10 g dropped 1.1 mmol/L, and the 15 g group saw a 1.2 mmol/L decrease. At day 29, 71% of patients on the 5 g dose maintained normal potassium, compared with 76% on 10 g and 85% on 15 g.
Long-Term Potassium Control
Lokelma isn’t just effective in the short term. A year-long open-label study tracked patients on maintenance therapy and found that normal potassium levels were sustained well over time. Among patients with more advanced kidney disease (the group most prone to recurring high potassium), 76% had normal levels at day 8 and 82% at day 365. For those with milder kidney disease, the numbers were even better: 88% at day 8 and 90% at one year. So the drug doesn’t lose effectiveness over time, and for many patients, potassium control actually improves slightly as dosing is optimized.
How Lokelma Works
Lokelma is a powder you mix with water and drink. Once it reaches your digestive tract, it acts like a selective trap. The drug’s crystal structure preferentially captures potassium ions and exchanges them for hydrogen and sodium. That potassium then leaves your body through stool instead of staying in your bloodstream. Each gram of Lokelma binds roughly 3 mmol of potassium. The drug itself is not absorbed into your body, so it stays entirely within the gut.
Side Effects to Know About
Because Lokelma swaps potassium for sodium, the main side effect to watch for is fluid retention (edema). The risk scales with the dose. In clinical trials, edema occurred in 1.8% of patients taking 5 g, 5.3% at 10 g, and 14.3% at 15 g, compared to 1.7% on placebo. This is particularly relevant if you have heart failure or kidney disease, since extra sodium and fluid can worsen those conditions.
When edema did occur in trials, about half the cases were managed by starting or adjusting a diuretic. The rest resolved without any treatment. Your prescriber will likely monitor for swelling, especially at higher doses.
One practical advantage of Lokelma over older potassium binders is that it has minimal impact on other medications. A study of nine commonly prescribed drugs, including blood thinners, cholesterol medications, thyroid hormone, and blood pressure pills, found no clinically meaningful interactions when taken alongside Lokelma. Unlike some older alternatives, it does not require you to stagger your other medications by hours.